Abcam PLC
LSE:ABC
Abcam PLC
LSE:ABC
Price:
1 226 GBX
11.15%
Market Closed
Updated:
May 15, 2024
Abcam PLC
EPS (Diluted)
|
Abcam PLC
EPS (Diluted) Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abcam PLC
LSE:ABC
|
EPS (Diluted)
£0
|
CAGR 3-Years
-49%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-14%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
EPS (Diluted)
-$1
|
CAGR 3-Years
-136%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
EPS (Diluted)
-$1
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
EPS (Diluted)
-$3
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
EPS (Diluted)
-£1
|
CAGR 3-Years
14%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
EPS (Diluted)
£0
|
CAGR 3-Years
-8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
2%
|
See Also
What is Abcam PLC's EPS (Diluted)?
EPS (Diluted)
0
GBP
0
GBP
Based on the financial report for Jun 30, 2022, Abcam PLC's EPS (Diluted) amounts to 0 GBP.
What is Abcam PLC's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
-14%
-14%
Over the last year, the EPS (Diluted) growth was -57%. The average annual EPS (Diluted) growth rates for Abcam PLC have been -49% over the past three years , -32% over the past five years , and -14% over the past ten years .
You don't have any saved screeners yet
